Biofrontera Inc. provided preliminary revenue guidance for the second quarter, first half and full-year of 2023. For the second quarter, the company anticipated Revenues to be in the range of approximately $5.7 million to $5.9 million, an increase of approximately 26% to 31% compared with the second quarter of 2022.

For the first half, the company anticipated revenue to be in the range of approximately $14.4 million to $14.6 million, representing growth of approximately 1% to 3% compared with the first half of 2022.

For the full year, the company affirms its previously announced expectations for full-year 2023 growth in revenue to be at least 25% compared with 2022.